Alligator – which has developing mitazalimab on its own after losing Johnson & Johnson as a partner for the drug a few years ...

Faced with a cash crunch, Alligator Biosciences has said it plans to shed up to 70% of its workforce and focus all its ...

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma ...

Four years after buying exclusive US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker ...

The world has woken up to a new era, with Donald Trump elected as US president – a huge victory for a political outsider and the 'silent majority' who felt sidelined by the status quo.

Assessing the value of new medical interventions and ensuring the appropriate care pathways are in place has become ever more critical as tightening healthcare budgets are combined with aging ...

In our patients focus month, we speak with Graeme Duncan of Healthcare at Home Ltd on the benefits that home healthcare can bring to patients. Home healthcare is the fastest growing sector in the ...

Greater collaboration can also provide a sense of belonging to patients, which Wolfe says is hugely important. “A lot of us who have chronic diseases have felt different from the rest of the ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

Companies specialising in artificial intelligence (AI) in healthcare are in “rude health” and are set for exponential growth over the next five years, according to a new report. The report by ...

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an ...